Clinical trial
Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder…
NCT00318162 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00318162 |
|---|---|
| Title | Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD) |
| Official title | Randomized Double-Blind Trial of Low-Dose Naltrexone for Children With PDD |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Jerusalem Institute for Child Development |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pervasive Developmental Disorder |
| Intervention type | Drug |
| Interventions | low dose naltrexone |
| Enrollment | 50 |
| First posted | Apr 26, 2006 |
| Last update posted | May 3, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: